Educational information, not medical advice — ask your doctor or midwife.
Track Punarnavadi Mandur with reminders and record whether it helped, in the app.
Punarnavadi Mandur is a classical Ayurvedic polyherbal-mineral compound described in texts like the Ashtanga Hridayam and Charaka Samhita. Its name comes from its key herb, Punarnava, meaning 'one that renews the body,' combined with Mandur, which is purified iron oxide processed through a traditional detoxification method called shodhana. The formula blends this iron source with digestive herbs, liver tonics, and diuretics to create a compound traditionally used across India for anemia, fluid retention, and liver-kidney disorders.
The purified iron in Mandur is thought to be more gently absorbed than raw iron, while the surrounding herbs may work together to support that process. Punarnava has been traditionally valued for diuretic and kidney-supporting properties that may help reduce fluid accumulation. Trikatu spices are believed to boost digestive fire (agni) to improve nutrient absorption, while Triphala is traditionally used to support liver function and gut health — together thought to help the body make use of the iron it is taking in.
Most commonly available as round tablets or traditional pills (vatis) in doses of 250–500 mg each. Powdered forms exist but are less common commercially. Tablet form is preferred for dosage accuracy and ease of use.
Punarnavadi Mandur has been prescribed in classical Ayurvedic practice for over 1,000 years, appearing in Vagbhata's Ashtanga Hridayam (Chikitsa Sthana) and Charaka Samhita as a primary treatment for Pandu (iron-deficiency anemia) and Shotha (edema). It remains one of the most widely prescribed iron formulations in Ayurvedic clinical practice across India today.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.